113 related articles for article (PubMed ID: 9030610)
1. Soluble human urokinase receptor is composed of two active units.
Higazi AA; Mazar A; Wang J; Quan N; Griffin R; Reilly R; Henkin J; Cines DB
J Biol Chem; 1997 Feb; 272(8):5348-53. PubMed ID: 9030610
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor.
Higazi A; Cohen RL; Henkin J; Kniss D; Schwartz BS; Cines DB
J Biol Chem; 1995 Jul; 270(29):17375-80. PubMed ID: 7615542
[TBL] [Abstract][Full Text] [Related]
3. Single-chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1.
Higazi AA; Mazar A; Wang J; Reilly R; Henkin J; Kniss D; Cines D
Blood; 1996 May; 87(9):3545-9. PubMed ID: 8611676
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the single-chain urokinase-urokinase receptor complex activity by plasminogen and fibrin: novel mechanism of fibrin specificity.
Higazi AA; Ajawi F; Akkawi S; Hess E; Kuo A; Cines DB
Blood; 2005 Feb; 105(3):1021-8. PubMed ID: 15353482
[TBL] [Abstract][Full Text] [Related]
5. The kringle stabilizes urokinase binding to the urokinase receptor.
Bdeir K; Kuo A; Sachais BS; Rux AH; Bdeir Y; Mazar A; Higazi AA; Cines DB
Blood; 2003 Nov; 102(10):3600-8. PubMed ID: 12881310
[TBL] [Abstract][Full Text] [Related]
6. Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins.
Higazi AA; Upson RH; Cohen RL; Manuppello J; Bognacki J; Henkin J; McCrae KR; Kounnas MZ; Strickland DK; Preissner KT; Lawler J; Cines DB
Blood; 1996 Jul; 88(2):542-51. PubMed ID: 8695802
[TBL] [Abstract][Full Text] [Related]
7. A region in domain II of the urokinase receptor required for urokinase binding.
Bdeir K; Kuo A; Mazar A; Sachais BS; Xiao W; Gawlak S; Harris S; Higazi AA; Cines DB
J Biol Chem; 2000 Sep; 275(37):28532-8. PubMed ID: 10864923
[TBL] [Abstract][Full Text] [Related]
8. Lysis of plasma clots by urokinase-soluble urokinase receptor complexes.
Higazi AA; Bdeir K; Hiss E; Arad S; Kuo A; Barghouti I; Cines DB
Blood; 1998 Sep; 92(6):2075-83. PubMed ID: 9731065
[TBL] [Abstract][Full Text] [Related]
9. Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2.
Larusch GA; Merkulova A; Mahdi F; Shariat-Madar Z; Sitrin RG; Cines DB; Schmaier AH
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H305-20. PubMed ID: 23709605
[TBL] [Abstract][Full Text] [Related]
10. Regulation of single chain urokinase binding, internalization, and degradation by a plasminogen activator inhibitor 1-derived peptide.
Zhang L; Strickland DK; Cines DB; Higazi AA
J Biol Chem; 1997 Oct; 272(43):27053-7. PubMed ID: 9341144
[TBL] [Abstract][Full Text] [Related]
11. Novel interactions between urokinase and its receptor.
Shliom O; Huang M; Sachais B; Kuo A; Weisel JW; Nagaswami C; Nassar T; Bdeir K; Hiss E; Gawlak S; Harris S; Mazar A; Higazi AA
J Biol Chem; 2000 Aug; 275(32):24304-12. PubMed ID: 10801829
[TBL] [Abstract][Full Text] [Related]
12. Urokinase receptor-dependent upregulation of smooth muscle cell adhesion to vitronectin by urokinase.
Chang AW; Kuo A; Barnathan ES; Okada SS
Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1855-60. PubMed ID: 9848876
[TBL] [Abstract][Full Text] [Related]
13. Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile.
Murciano JC; Higazi AA; Cines DB; Muzykantov VR
J Control Release; 2009 Nov; 139(3):190-6. PubMed ID: 19616049
[TBL] [Abstract][Full Text] [Related]
14. The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction.
Høyer-Hansen G; Behrendt N; Ploug M; Danø K; Preissner KT
FEBS Lett; 1997 Dec; 420(1):79-85. PubMed ID: 9450554
[TBL] [Abstract][Full Text] [Related]
15. Crystallization of soluble urokinase receptor (suPAR) in complex with urokinase amino-terminal fragment (1-143).
Huang M; Mazar AP; Parry G; Higazi AA; Kuo A; Cines DB
Acta Crystallogr D Biol Crystallogr; 2005 Jun; 61(Pt 6):697-700. PubMed ID: 15930623
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect.
Resnati M; Guttinger M; Valcamonica S; Sidenius N; Blasi F; Fazioli F
EMBO J; 1996 Apr; 15(7):1572-82. PubMed ID: 8612581
[TBL] [Abstract][Full Text] [Related]
17. Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor.
Høyer-Hansen G; Pessara U; Holm A; Pass J; Weidle U; Danø K; Behrendt N
Biochem J; 2001 Sep; 358(Pt 3):673-9. PubMed ID: 11535128
[TBL] [Abstract][Full Text] [Related]
18. Cell-surface acceleration of urokinase-catalyzed receptor cleavage.
Høyer-Hansen G; Ploug M; Behrendt N; Rønne E; Danø K
Eur J Biochem; 1997 Jan; 243(1-2):21-6. PubMed ID: 9030717
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the ternary complex formation of human urokinase with the separated two domains of its receptor.
Oda M; Shiraishi A; Hasegawa M
Eur J Biochem; 1998 Sep; 256(2):411-8. PubMed ID: 9760182
[TBL] [Abstract][Full Text] [Related]
20. Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization.
Sidenius N; Andolfo A; Fesce R; Blasi F
J Biol Chem; 2002 Aug; 277(31):27982-90. PubMed ID: 12034711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]